Know Cancer

or
forgot password

Melanoma Family Case-Control Study Protocol


N/A
18 Years
N/A
Open (Enrolling)
Both
Melanoma (Skin)

Thank you

Trial Information

Melanoma Family Case-Control Study Protocol


OBJECTIVES:

Primary

- Determine what lifestyle factors and which genes govern relapse from melanoma.

Secondary

- Compare sun exposure and genes that cause melanoma in patients with melanoma vs healthy
participants.

- Assess how unusual moles relate to sun exposure and genes that cause melanoma.

OUTLINE: This is a multicenter, cohort study.

Patients and healthy participants complete lifestyle questionnaires by mail and telephone.
Some patients* and healthy participants undergo a skin examination to count moles and
classify skin type (e.g., degree of freckling and wrinkling indicative of sun damage).

NOTE: *Patients diagnosed with primary invasive melanoma after September 2005 do not need to
consent to a skin examination.

Patients and healthy participants also undergo blood collection for lymphocyte analysis, DNA
extraction, and the measurement of minerals, vitamins, and beta carotene. Tissue samples
from original diagnosis are examined by immunohistochemistry for gene expression and
mutations, including CDKN2A and CDK4.

Patients and healthy participants are followed annually.

Peer reviewed and funded or endorsed by Cancer Research UK

PROJECTED ACCRUAL: A total of 3,700 patients and healthy participants will be accrued for
this study.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Meets 1 of the following criteria:

- Newly diagnosed primary invasive melanoma (patient group)

- Lentigo maligna malignant melanoma allowed

- Rare variants of melanoma allowed, including any of the following:

- Acral lentiginous

- Subungual

- Ear, nose, and throat

- Oropharyngeal

- Perineal

- Vaginal

- Vulval

- Rectal

- Nodal with no known primary

- Patients undergoing sentinel node biopsy are eligible

- No in situ melanoma, melanocytic intraepidermal neoplasia, or ocular
melanoma

- Healthy participant meeting either of the following criteria (control group):

- Relative of a patient who was diagnosed with melanoma after September 2005

- Healthy volunteer who is age- and sex-matched for patients who were
diagnosed with melanoma before October 2005

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

Lifestyle factors governing relapse from melanoma

Principal Investigator

Julia Newton Bishop, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Leeds Cancer Centre at St. James's University Hospital

Authority:

Unspecified

Study ID:

CDR0000532934

NCT ID:

NCT00445783

Start Date:

July 2000

Completion Date:

Related Keywords:

  • Melanoma (Skin)
  • lentigo maligna malignant melanoma
  • stage IV melanoma
  • acral lentiginous malignant melanoma
  • nodular malignant melanoma
  • stage IA melanoma
  • stage IB melanoma
  • stage IIA melanoma
  • stage IIB melanoma
  • stage IIC melanoma
  • stage IIIA melanoma
  • stage IIIB melanoma
  • stage IIIC melanoma
  • Melanoma

Name

Location